How to Buy Neogenomics Stock
Neogenomics Inc
NeoGenomics, Inc. operates a network of cancer-focused testing laboratories in the United States, Europe, and Asia. It operates through, Clinical Services and Pharma Services segments.
Neogenomics stock last closed at $14.03, down 0.92% from the previous day, and has decreased 9.72% in one year. It has underperformed other stocks in the Diagnostics & Research industry by 0.04 percentage points. Neogenomics stock is currently +27.2% from its 52-week low of $11.03, and -33.88% from its 52-week high of $21.22.
As of Apr 24, 2024, there are 127.61M NEO shares outstanding. The market value of NEO is $1.79B. In the last 24 hours, 539,046 NEO shares were traded.
How to Buy Neogenomics Stock
Wondering how to invest in Neogenomics stock? Here's how.
- Choose where to buy Neogenomics stock: You need to choose an online brokerage, but don't worry - we've analyzed dozens of online brokerages and apps to help you determine where to buy Neogenomics stock.
- Sign up for your brokerage account: Sign up for 0% commission trading with the highest-rated brokerage we've found.
- Deposit funds into your brokerage account: Pick your payment method and add your info.
- Analyze Neogenomics stock: The Neogenomics ticker symbol is NEO. Is Neogenomics stock a good investment? Should you buy shares of NEO? How do NEO's underlying business fundamentals look? Do top analysts think Neogenomics is a good buy? Why has NEO's stock price moved recently? (Hint: Our stock market research website can help you understand if NEO is a good stock to buy).
- Make your NEO trade: Decide if you will purchase NEO shares at the current market price or use a limit order to buy NEO shares at a given price.
- Keep an eye on your NEO investment: Create a watchlist to monitor your investment in Neogenomics shares.
Step 1: Choose where to buy Neogenomics stock
You will need a brokerage account in order to access the NASDAQ market and buy NEO shares.
Our favorite brokerage: eToro
In our opinion, eToro is the best stock brokerage. Here's why:
- Invest in stocks with zero commissions: Invest without commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still buy the stock.
- Access to world financial markets: From Tech to Financial Services, New York to Shanghai — you can fill your portfolio with stocks from the globe's leading exchanges.
- Social investing: eToro has a community of more than 20 million users globally. Talk to, learn from, and copy the unique crypto portfolios of other investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other assets: Such as ETFs and cryptos.
Get $10 towards your purchase of stock by creating an account with eToro now.
Open eToro AccountStep 2: Sign up for your brokerage account
Now that you've chosen the right brokerage, it's time to fill out some personal details so you can invest in NEO stock today.
How to Open a New Investment Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Enter your personal data to create a new brokerage account.
- Send your info by hitting the "Create Account" button. Get started with eToro today
Step 3: Deposit funds into your brokerage account
Now that you've finished signing up on the best app for stock investing, you can securely and quickly fund your account:
Watch the video below for more details transferring funds into your new brokerage account.
Step 4: Analyze Neogenomics stock
After you have figured out the best place to buy Neogenomics stock, it's crucial to research their stock prior to investing, so you truly wrap your head around the risk as well as the opportunity.
Neogenomics Numbers
Neogenomics Due Diligence Checks
WallStreetZen was created to help everyday investors perform more in-depth fundamental analysis in minutes instead of hours.
You can see all of the due diligence checks on NEO's stock page.
Is NEO stock undervalued or overvalued?
Investors use many financial metrics, analyses, models, and charts to gauge NEO's true value.
Using relative valuations metrics:
- NEO could be undervalued based on its P/B ratio of 1.9x, relative to Diagnostics & Research industry P/B ratio of 4.22x
You can access additional valuation analysis on NEO's stock here.
NEO Financial Health Overview
Positive Health Checks:
- NEO has cash burn of 30705000. It has sufficient cash and short-term investments to cover this for at least one year.
- There are more short-term assets than short-term liabilities on the NEO balance sheet.
- NEO profit margin has gone up from -28.3% to -14.9% in the past year.
- NEO has $415.20M in cash and short term investments. This is sufficient to cover its annual cash burn of $30.71M.
Negative Health Checks:
- NEO has a relatively high debt to equity ratio of 0.79.
- Total NEO debt is higher than 5 years ago, relative to shareholder equity.
- There are more long-term liabilities than short-term assets on the NEO balance sheet.
Is Neogenomics stock a Buy, Hold, or Sell, according to analysts?
Out of 6 Wall Street analysts who give recommendations on NEO, the consensus analyst rating on Neogenomics is a Strong Buy
It's important to keep in mind that analyst ratings are not recommendations, nor are they investment advice.
Most Recent NEO Analyst Forecasts
Tejas Savant, a bottom 15% analyst from Morgan Stanley maintains NEO with a hold rating and raises their NEO price target from $16.00 to $17.00, on Nov 8, 2023.
You can dig deeper into what analysts are forecasting on the Neogenomics stock forecast page.
Metrics for Advanced NEO Traders
Is NEO Growing Revenue?
Last year, NEO revenue was $591.64M. In the past 5 year, NEO's revenue has grown by 16.41% per year. This was faster than the Diagnostics & Research industry average of 12.4%.
You can analyze NEO's earnings and revenue performance here.
Who is buying/selling NEO?
In the past year, executives and large shareholders at NEO have sold more shares than they have bought.
Lynn A. Tetrault, Director of NEO, was the latest NEO insider to sell. They sold $97,578.08 worth of NEO stock on Mar 4, 2024.
Get more info about who owns NEO stock here.
Can I get consistent income from NEO stock?
No, Neogenomics doesn't provide an income stream by paying out dividends.
NEO Social Trading Data
One of the biggest reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to learn what other community members have to say.
Step 5: Make your NEO trade
You have two primary types of orders:
- Market order: A market order is an order to buy or sell a security at the best possible price.
Market orders are usually the best for newer investors. - Limit order: A limit order lets you buy or sell a security at a specific price (or better).
If you want to be sure you're buying or selling at a particular dollar amount, place a limit order.
Hit the Open button and eToro will execute the order.
If you want additional help buying stocks on eToro, click the helpful video below:
Step 6: Keep an eye on your NEO investment
Now that you own some NEO shares, you'll want to keep up with your new company.
Make a watchlist to track your NEO stock.
NEO Feed
How to Buy Stock in Neogenomics
To summarize, here are the 6 steps to buy Neogenomics stock:
- Choose where to buy Neogenomics stock
- Sign up for your brokerage account
- Deposit funds into your brokerage account
- Analyze Neogenomics stock
- Make your NEO trade
- Keep an eye on your NEO investment
If you need a place to buy stocks, eToro is our recommended option.
Get Started with eToro TodayIf you would like to get notifications regarding your new investment in Neogenomics, add NEO to your watchlist by clicking the button below.
Related "How To" Guides
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.